Erin M Rock1, Cheryl L Limebeer1, Reem Smoum2, Raphael Mechoulam2, Linda A Parker3. 1. Department of Psychology and Collaborative Neuroscience Program, University of Guelph, Guelph, ON, N1G2W1, Canada. 2. Institute of Drug Research, Medical Facility, Hebrew University of Jerusalem, Jerusalem, Israel. 3. Department of Psychology and Collaborative Neuroscience Program, University of Guelph, Guelph, ON, N1G2W1, Canada. parkerl@uoguelph.ca.
Abstract
RATIONALE: The fatty acid amide oleoyl glycine (OlGly) and its more stable methylated form oleoyl alanine (OlAla) reduce naloxone-precipitated morphine withdrawal (MWD)-induced conditioned gaping (nausea) responses in rats. In addition, OlGly has been shown to reduce lithium chloride (LiCl)-induced conditioned gaping in rats and vomiting in Suncus murinus (house musk shrews). OBJECTIVES: Here, we compared the potential of these fatty acid amides to maintain their anti-nausea/anti-emetic effect over a delay. The following experiments examined the potential of a wider dose range of OlGly and OlAla to interfere with (1) LiCl-induced conditioned gaping in rats and (2) LiCl-induced vomiting in shrews, when administered 20 or 70 min prior to illness. RESULTS: OlAla (1, 5, 20 mg/kg) reduced LiCl-induced conditioned gaping, with OlGly only effective at the high dose (20 mg/kg), with no effect of pretreatment delay time. At the high dose of 20 mg/kg, OlGly increased passive drips during conditioning suggesting a sedative effect. In shrews, both OlGly and OlAla (1, 5 mg/kg) suppressed LiCl-induced vomiting, with no effect of pretreatment delay. OlAla more effectively suppressed vomiting, with OlAla (5 mg/kg) also increasing the latency to the first vomiting reaction. CONCLUSIONS: OlAla was more effective than OlGly in reducing both LiCl-induced gaping in rats and LiCl-induced vomiting in shrews. These findings provide further evidence that these fatty acid amides may be useful treatments for nausea and vomiting, with OlAla demonstrating superior efficacy.
RATIONALE: The fatty acid amide oleoyl glycine (OlGly) and its more stable methylated form oleoyl alanine (OlAla) reduce naloxone-precipitated morphine withdrawal (MWD)-induced conditioned gaping (nausea) responses in rats. In addition, OlGly has been shown to reduce lithium chloride (LiCl)-induced conditioned gaping in rats and vomiting in Suncus murinus (house musk shrews). OBJECTIVES: Here, we compared the potential of these fatty acid amides to maintain their anti-nausea/anti-emetic effect over a delay. The following experiments examined the potential of a wider dose range of OlGly and OlAla to interfere with (1) LiCl-induced conditioned gaping in rats and (2) LiCl-induced vomiting in shrews, when administered 20 or 70 min prior to illness. RESULTS: OlAla (1, 5, 20 mg/kg) reduced LiCl-induced conditioned gaping, with OlGly only effective at the high dose (20 mg/kg), with no effect of pretreatment delay time. At the high dose of 20 mg/kg, OlGly increased passive drips during conditioning suggesting a sedative effect. In shrews, both OlGly and OlAla (1, 5 mg/kg) suppressed LiCl-induced vomiting, with no effect of pretreatment delay. OlAla more effectively suppressed vomiting, with OlAla (5 mg/kg) also increasing the latency to the first vomiting reaction. CONCLUSIONS: OlAla was more effective than OlGly in reducing both LiCl-induced gaping in rats and LiCl-induced vomiting in shrews. These findings provide further evidence that these fatty acid amides may be useful treatments for nausea and vomiting, with OlAla demonstrating superior efficacy.
Authors: Samantha M Ayoub; Reem Smoum; Mathew Farag; Harkirat Atwal; Stephen A Collins; Erin M Rock; Cheryl L Limebeer; Fabiana Piscitelli; Fabio Arturo Iannotti; Aron H Lichtman; Francesco Leri; Vincenzo Di Marzo; Raphael Mechoulam; Linda A Parker Journal: Psychopharmacology (Berl) Date: 2020-06-16 Impact factor: 4.530
Authors: C L Limebeer; V K Vemuri; H Bedard; S T Lang; K P Ossenkopp; A Makriyannis; L A Parker Journal: Br J Pharmacol Date: 2010-09 Impact factor: 8.739
Authors: Giulia Donvito; Fabiana Piscitelli; Pretal Muldoon; Asti Jackson; Rosa Maria Vitale; Enrico D'Aniello; Catia Giordano; Bogna M Ignatowska-Jankowska; Mohammed A Mustafa; Francesca Guida; Gavin N Petrie; Linda Parker; Reem Smoum; Laura Sim-Selley; Sabatino Maione; Aron H Lichtman; M Imad Damaj; Vincenzo Di Marzo; Raphael Mechoulam Journal: Neuropharmacology Date: 2018-03-19 Impact factor: 5.250
Authors: Shalini Chaturvedi; William J Driscoll; Brenda M Elliot; Martha M Faraday; Neil E Grunberg; Gregory P Mueller Journal: Prostaglandins Other Lipid Mediat Date: 2006-10-05 Impact factor: 3.072
Authors: David J Merkler; Geoffrey H Chew; Andrew J Gee; Kathleen A Merkler; Jean-Paul O Sorondo; Mitchell E Johnson Journal: Biochemistry Date: 2004-10-05 Impact factor: 3.162
Authors: Heather B Bradshaw; Neta Rimmerman; Sherry Shu-Jung Hu; Valery M Benton; Jordyn M Stuart; Kim Masuda; Benjamin F Cravatt; David K O'Dell; J Michael Walker Journal: BMC Biochem Date: 2009-05-21 Impact factor: 4.059